Medicines Distribution Consents




9 SEPTEMBER 2010 NEW ZEALAND GAZETTE, No. 115 3089

Product:
Mircera
Active Ingredient:
Methoxy polyethylene glycol epoetin beta 360μg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany

Product:
Mircera
Active Ingredient:
Methoxy polyethylene glycol epoetin beta 600μg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany

Product:
Mircera
Active Ingredient:
Methoxy polyethylene glycol epoetin beta 800μg
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (NZ) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany

Product:
Omeprazole IV - Rex
Active Ingredient:
Omeprazole sodium 42.6mg equivalent to 40mg omeprazole
Dosage Form:
Powder for infusion
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Salcette, India

Product:
Oxaliplatin
Active Ingredient:
Oxaliplatin 50mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Vianex SA, Pallini Attikis, Greece

Product:
Oxaliplatin
Active Ingredient:
Oxaliplatin 100mg
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
Vianex SA, Pallini Attikis, Greece

Product:
Timolol
Active Ingredient:
Timolol maleate 0.3417%w/v
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Salcette, India

Product:
Timolol
Active Ingredient:
Timolol maleate 0.6834%w/v
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Salcette, India

Dated this 3rd day of September 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7057

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product:
Dettol Antiseptic Wound Wash Spray
Active Ingredient:
Benzalkonium chloride 0.198%w/v
Dosage Form:
Topical spray
New Zealand Sponsor:
Reckitt Benckiser (New Zealand) Limited
Manufacturer:
Reckitt Benckiser Healthcare (UK) Limited, North Humberside, United Kingdom

Dated this 3rd day of September 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go7058



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 115





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines (continued from previous page)

🏥 Health & Social Welfare
3 September 2010
Medicines, Distribution, Mircera, Omeprazole, Oxaliplatin, Timolol
  • Janice Wilson, Deputy Director-General, Population Health Directorate, Ministry of Health

🏥 Consent to the Distribution of a New Related Product

🏥 Health & Social Welfare
3 September 2010
Medicines, Distribution, Dettol Antiseptic Wound Wash Spray
  • Janice Wilson, Deputy Director-General, Population Health Directorate, Ministry of Health